%PDF-1.6
%
1 0 obj
<>]/Pages 3 0 R/Type/Catalog/ViewerPreferences<>>>
endobj
2 0 obj
<>stream
uuid:8e869b3d-78c7-4e2b-97f6-71fa4e5078e0
adobe:docid:indd:9b1221f5-d792-11e0-999f-9eb7744ced9a
xmp.id:ae529234-2b15-8348-a6ce-e5553af1ec66
proof:pdf
1
xmp.iid:1a27d534-a855-7548-8d1e-51d4ea6e9b19
adobe:docid:indd:9b1221f5-d792-11e0-999f-9eb7744ced9a
adobe:docid:indd:9b1221f5-d792-11e0-999f-9eb7744ced9a
default
converted
from application/x-indesign to application/pdf
Adobe InDesign 16.4 (Windows)
/
2022-12-07T16:45:46+09:00
2022-12-07T16:45:46+09:00
2022-12-07T16:45:46+09:00
2022-12-07T16:45:46+09:00
Adobe InDesign 16.4 (Windows)
application/pdf
目次.indd
Adobe PDF Library 16.0
False
PDF/X-4
PDF/X-4
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
</LastModified/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID/PageItemUIDToLocationDataMap<0[4151.0 0.0 3.0 -823.465 -406.772 -720.0 -369.921 1.0 0.0 0.0 1.0 -714.567 -338.976]>>/PageTransformationMatrixList<0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<0 190>>/PageWidthList<0 595.276>>>>>>/Resources<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 595.276 841.89]/Type/Page>>
endobj
7 0 obj
</LastModified/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID/PageItemUIDToLocationDataMap<0[4151.0 0.0 3.0 -823.465 -406.772 -720.0 -369.921 1.0 0.0 0.0 1.0 -714.567 -338.976]>>/PageTransformationMatrixList<0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<0 10401>>/PageWidthList<0 595.276>>>>>>/Resources<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 595.276 841.89]/Type/Page>>
endobj
18 0 obj
<>stream
BT
0 0 0 1 k
/Perceptual ri
/GS0 gs
/T1_0 1 Tf
14.8819 0 0 14.8819 103.7394 758.6716 Tm
[(J)15 (apanese J)15 (our)15 (nal of Pharmaceutical Health Car)18 (e and Sciences)]TJ
/C0_0 1 Tf
9.9213 0 0 9.9213 216.2847 742.4503 Tm
<02A200370050004D000100150019027C002F0050000100120013000D02790025004600440046004E0043004600530279001300110013001302A3>Tj
4.37 -1.714 Td
[<02950295>-250 <00240050004F00550046004F00550054>-249.9 <02950295>]TJ
/C0_1 1 Tf
-0.227 -3.143 Td
<02BB>Tj
/T1_0 1 Tf
-0.055 Tw 1 0.05 Td
(Regular Articles)Tj
/C0_1 1 Tf
0 Tw 6.971 -0.05 Td
<02BC>Tj
/T1_1 1 Tf
10.6299 0 0 10.6299 65.1968 675.2125 Tm
[(An )55 (Analysis of the Relationship between Gene Polymorphisms in Serotonin-Rel\
ated Genes and )]TJ
10.6299 0 0 10.6299 474.4122 675.2125 Tm
( )Tj
/C0_0 1 Tf
10.6299 0 0 10.6299 65.1968 658.9133 Tm
<0279>Tj
/T1_1 1 Tf
[(Chemotherap)10 (y-Induced Gastrointestinal Symptoms)]TJ
9.9213 0 0 9.9213 141.7323 643.2377 Tm
( )Tj
/C0_0 1 Tf
0.286 0 Td
<029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C>Tj
/T1_1 1 Tf
22.423 0 Td
[(R Uchino, M Nakamura, )55 (A )90 (Y)110 (oshimi, )]TJ
1.249 -1.5 Td
[(M Miyazaki, K )90 (Y)100 (amada, )90 (Y Noda)]TJ
13.328 0 Td
( )Tj
/C0_0 1 Tf
0 0 Td
<029C>Tj
/T1_2 1 Tf
9.2126 0 0 9.2126 527.2236 629.0858 Tm
(529)Tj
/T1_1 1 Tf
10.6299 0 0 10.6299 65.1968 596.5511 Tm
[(Combination of MPC Polymer Enhances the Dry Eye )18 (Therap)10 (y in Commercially )55 (A)74 (v)25 (ailable Diquafosol Sodium)]TJ
/C0_0 1 Tf
0 -1.533 Td
<0279>Tj
/T1_1 1 Tf
(and Sodium Hyaluronate Eye Drops)Tj
9.9213 0 0 9.9213 141.7322 564.5764 Tm
( )Tj
/C0_0 1 Tf
0.286 0 Td
<029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C>Tj
/T1_1 1 Tf
21.124 0 Td
[(N Nag)5 (ai, R Goto, S )30 (W)80 (atanabe, M )90 (Y)111 (uno, )]TJ
4.422 -1.5 Td
[(T K)35 (osaka, H Otak)10 (e, )55 (A Sumi, )]TJ
0.013 -1.5 Td
(Y Sasaki, M Hara, E Harata)Tj
11.441 0 Td
( )Tj
/C0_0 1 Tf
0 0 Td
<029C>Tj
/T1_2 1 Tf
9.2126 0 0 9.2126 527.2236 535.5426 Tm
(545)Tj
/C0_2 1 Tf
9.9213 0 0 9.9213 280.1227 490.8756 Tm
<02BB>Tj
/T1_0 1 Tf
1 0.05 Td
(Notes)Tj
/C0_2 1 Tf
2.388 -0.05 Td
<02BC>Tj
/T1_1 1 Tf
10.6299 0 0 10.6299 65.1968 471.8268 Tm
[(Ef)25 (fect of Collaboration between a Community Pharmacist and Ph)5 (ysical )18 (Therapist on P)15 (atients with COPD)]TJ
9.9213 0 0 9.9213 141.7322 456.1512 Tm
( )Tj
/C0_0 1 Tf
0.286 0 Td
<029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C>Tj
/T1_1 1 Tf
23.172 0 Td
[(Y Urag)5 (ami, )90 (Y Mizob)20 (uchi, M Seki, )]TJ
6.048 -1.5 Td
[(Y )90 (Y)100 (amaji, N Iihara)]TJ
7.78 0 Td
( )Tj
/C0_0 1 Tf
0 0 Td
<029C>Tj
/T1_2 1 Tf
9.2126 0 0 9.2126 527.2236 441.9992 Tm
(551)Tj
/T1_1 1 Tf
10.6299 0 0 10.6299 65.1968 409.4646 Tm
[(Ev)25 (aluation of the Usefulness of Collaboration between Pharmacists and )]TJ
/C0_0 1 Tf
0 -1.533 Td
<0279>Tj
/T1_1 1 Tf
[(Clinical Engineers Re)15 (g)5 (arding the Use of Extracorporeal Circulation De)25 (vices in Intensi)25 (v)15 (e Care Settings)]TJ
9.9213 0 0 9.9213 141.7322 377.4898 Tm
( )Tj
/C0_0 1 Tf
0.286 0 Td
<029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C>Tj
/T1_1 1 Tf
21.409 0 Td
[(Y K)35 (obayashi, )17.9 (T Nakag)5 (a)15 (w)10 (a, )18 (T Ka)15.1 (w)10 (azu, )]TJ
0.749 -1.5 Td
[(N Moriasa, M )55 (Araka)15 (w)10 (a, )18 (T Karasuno)]TJ
14.842 0 Td
( )Tj
/C0_0 1 Tf
0 0 Td
<029C>Tj
/T1_2 1 Tf
9.2126 0 0 9.2126 527.2236 363.3378 Tm
(562)Tj
/T1_1 1 Tf
10.6299 0 0 10.6299 65.1968 330.8032 Tm
[(Influence of De)25 (v)15 (elopment of Proton Pump Inhibitors and )]TJ
/C0_0 1 Tf
0 -1.533 Td
<0279>Tj
/T1_1 1 Tf
[(Potassium-competiti)25 (v)15 (e )55 (Acid Block)10 (ers on )]TJ
/T1_3 1 Tf
17.561 0.05 Td
[(Clostridioides Dif)18 (f)19.9 (icile )]TJ
/T1_1 1 Tf
9.408 -0.05 Td
(Infection)Tj
9.9213 0 0 9.9213 141.7322 298.8283 Tm
( )Tj
/C0_0 1 Tf
0.286 0 Td
<029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C>Tj
/T1_1 1 Tf
25.423 0 Td
[(A )30 (W)80 (atanabe, J K)15 (ubo, )18 (T Sato, )]TJ
-1.313 -1.5 Td
[(S )18 (T)80 (akatori, M Iw)10 (ahori, H Izumi, )]TJ
0 0 0 0 k
/GS1 gs
-24.396 -1.5 Td
( )Tj
/C0_0 1 Tf
0.286 0 Td
<029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C029C>Tj
0 0 0 1 k
/GS0 gs
/T1_1 1 Tf
25.116 0 Td
[(H )18 (T)80 (abata, )89.9 (Y K)35 (ohara, K Hiura)]TJ
11.884 0 Td
( )Tj
/C0_0 1 Tf
0 0 Td
<029C>Tj
/T1_2 1 Tf
9.2126 0 0 9.2126 527.2236 269.7945 Tm
(570)Tj
ET
endstream
endobj
13 0 obj
<>
endobj
12 0 obj
<>
endobj
20 0 obj
<>
endobj
21 0 obj
<>
endobj
15 0 obj
<>
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
34 0 obj
<>
endobj
35 0 obj
<>stream
H\j0~
Cq)e{V:b='ۥ,gvϝ 6bo^"xՆ(-r$%ܙ2!Pq ~͓#n
6W|xsg4
hP8Q3O]ú#ߍ!T\aUA(h5 .F,'=x&x((0q'@|| s:?f>F3בϙϑmKfLsS)S ᑼyO'IDGǫ9Tq_
endstream
endobj
36 0 obj
<>stream
HS}PSWX5T^yݼtmEkV֮UlZ
'/!! GBH+||PuEPW3VaյLwǾ0wwϹ3XxxyStf]YӪCo.
W>:ppY2}//#W8:y6%Z4 ڼ|3^BnYĄ&lXMx
6r;4\K̼%FQPyznNǥR4bɜĩ8zp3>^y
Շ*:_k
O8H+4i-I0/Kf^2r`>~ǩNqRj SY%֤ѪZBI4!åvɰ1,bXz&Òda{®ޑYeOBoZeg~Cg$%BBChv$xY(q9|lo@lyzY,5S{v2ȆQ%ʆD's㣬J܅- VF0Y9X|OhP~Qר X9PuڭUX:OE-S=*bPR fR`3+ {-WHEŦkf~yqgl'>2xVeIO$w1k/<0v
[[H֡(p}CJyKݐlF>W+U[FT'}շQZK}Y*ʔ;Z`}>auUYtG#.op%.iTmz*pD4=hmFgL_ Bm%Uf_ǘRqB||E7duћfzOYnX0EWidT7;::پZ>{q]OF
<ܯOnkRʑS7E]8Z3#O? (aJ] *zL%J/d`id>6|O N#/4@L*'[V+TnpLDQGIk"z/@_L+pp'WF:".ָ
Ug+lW/匲_t](?;6ءsm]s-((:(0žWFLh\2J3*2*#-Bւ\8eQk;s~Nq}'C8PwJ*ڌOuHP$fpې#Wᕧᬜ~~]s2zB,_ybZ&I
AS74.~-?FK
X럂92]MM5M`R[~݊&9W%+O3ۨ =4MDIe7מha`٢ʳ^SC]J/$Ko%$5tWۥ5ì.Pnk]Sr(zV8)>%{N~EJYE:=.wKh)+ʊH縧[*;QQ(J-V;.?@L;XWHxD<$An:k̵%- 0"5P\d蕙00 2?$D
endstream
endobj
32 0 obj
<>
endobj
33 0 obj
<>stream
H\j }ܽXL=hHt
1yeP?g橱&|Na0VB"/@omVS$qNTJ1{ԮǽoAc0v݃lpB!]nBhʛHwsŶϓ4ξS:;2gZeRlB'Ι1|N|f$0˚Z]E{j z%ox_ f
endstream
endobj
37 0 obj
<>stream
H4mL[emw .l^}f]@;KJ燱d^nK54a
RlcQL4FEY5~Yb#8_rn95z/?y症eve:9^9[w[v9yZRK(K]%So3}-x'Y^[^asjZ#53^<0F錝|1vNgԙuC, ArN7Q70vQ!va2[bP 8` &;(匘7ۓXcz8*.ESA '֔iV=neOFGQV8P'ٛ`hL8'w!/&T^n/gڒ/`Y;ESf M)A)+ ~u^m҆M<4q__^Un yƷՅjoiVǍ^6鞩|?8tCU(bhHcq[pj[4,P@+P$XW2!FOKPB+anvoKBԃqWoF'cLiЃeh&T9C`Sb<
_Y0
}=JCkPvͼ%hܡ~ch?<+g+T+|}Xeaݧb{!70Ld~Xƣ;CL$1-fhveX2[7q_1k#'36LJneO .)
endstream
endobj
30 0 obj
<>
endobj
31 0 obj
<>stream
H\n0<"!"I+e1?<